Janaxa Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 05-07-2024
- Paid Up Capital ₹ 1.00 M
as on 05-07-2024
- Company Age 12 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.45 M
as on 05-07-2024
- Revenue 18.26%
(FY 2022)
- Profit 29.77%
(FY 2022)
- Ebitda 57.41%
(FY 2022)
- Net Worth 24.22%
(FY 2022)
- Total Assets 15.96%
(FY 2022)
About Janaxa Pharmaceuticals
The Corporate was formerly known as Lab Corp India Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹5.45 M.
Manoj Kumar and Rahul Khosla serve as directors at the Company.
- CIN/LLPIN
U24232CH2012PTC033849
- Company No.
033849
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Jun 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, Chandigarh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Janaxa Pharmaceuticals Private Limited offer?
Janaxa Pharmaceuticals Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Nutraceuticals & Dietary Supplements, Dietary Supplements, Common Disease Medicines, Pharmaceutical Tablets, Pharmaceutical Medicine, Digestive System Drugs & Medicines, Antacid Drugs, Injectable Products.
Who are the key members and board of directors at Janaxa Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rahul Khosla  | Director | 07-Jun-2012 | Current |
| Manoj Kumar | Director | 13-Jan-2014 | Current |
Financial Performance of Janaxa Pharmaceuticals.
Janaxa Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 18.26% increase. The company also saw a substantial improvement in profitability, with a 29.77% increase in profit. The company's net worth Soared by an impressive increase of 24.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Janaxa Pharmaceuticals?
In 2022, Janaxa Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 11 Jan 2022 | ₹3.50 M | Open |
Others Creation Date: 06 Oct 2021 | ₹1.00 M | Open |
Others Creation Date: 03 May 2019 | ₹0.95 M | Open |
How Many Employees Work at Janaxa Pharmaceuticals?
Unlock and access historical data on people associated with Janaxa Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Janaxa Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Janaxa Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
